Last10K.com

Medicure Inc (MCUJF) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, March 31, 2022

Medicure Inc

HISTORY TOOLS
CIK: 1133519 Ticker: MCUJF

View differences made from one to another to evaluate Medicure Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Medicure Inc.

Continue

Assess how Medicure Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Medicure Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Medicure Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Q1 Financial Statements
Exhibit 99.2: Q1 Md&Amp;A
Exhibit 99.3: Ceo Certification
Exhibit 99.4: Cfo Certification
Ticker: MCUJF
CIK: 1133519
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001279569-22-000899
Submitted to the SEC: Tue May 31 2022 6:38:54 AM EST
Accepted by the SEC: Tue May 31 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mcujf/0001279569-22-000899.htm